In regards to prostate cancer, the classic radiotherapy dose ranges from 70-80 Gy, administered in daily 2-Gy fractions.
However, when taking into account the particular radiobiological model of prostate cancer cells, one realizes that there is a potential theoretical advantage to delivering a greater biological effective dose per treatment in a lower number of fractions. Both recent and older publications have attempted to explore this treatment option. This critical review comprehensively examines the current state of knowledge concerning hypofractionated radiotherapy in prostate cancer.
Written by:
Vavassis P, Nguyen DH, Bahary JP, Yassa M. Are you the author?
Department of Radiation Oncology, Hôpital Maisonneuve-Rosemont, 5415 Boulevard de l'Assomption, Montréal, QC H1T 2M4, Canada.
Reference: Expert Rev Anticancer Ther. 2012 Jul;12(7):965-72.
doi: 10.1586/era.12.70
PubMed Abstract
PMID: 22845411
UroToday.com Prostate Cancer Section
